Christine Sheehy

Coeptis Therapeutics, Inc. is a pharmaceutical company focused on the development of therapeutics and technologies to disrupt conventional treatment paradigms. Its product portfolio includes CD38-GEAR-NK and a CD38-Diagnostic, which is focused on CD38-related cancers. The company was founded on February 15, 1996 and is headquartered in Wexford, PA.

Three Rivers Pharmaceuticals LLC develops, manufactures, and markets pharmaceutical therapies. Its medicines include Amphotec/Amphocil and Ribasphere for use in combination with interferon alfa-2b in the US. The firm was founded by Donald J. Kerrish, Paul F. Fagan, and Patrick L. Kerrish in April, 2000 and is headquartered in Cranberry Township, PA.

Schneider Downs & Co., Inc. is a regional accounting and business consulting firm that provides tax, audit, and business advisory services to public and private companies and nonprofit organizations. The private company is based in Pittsburgh, PA, and has subsidiaries in the United States. The firm offers more than 80 services from five business units, including assurance and tax advisors, business advisors, technology advisors, wealth management advisors, and corporate finance advisors. Schneider Downs partners with clients to provide comprehensive IT audits and compliance reviews that ensure effective and efficient technology controls that better align the technology function with their business and risk strategies. Steven D. Thompson has been the CEO of the company since 2001.

Kadmon Pharmaceuticals LLC manufactures and distributes pharmaceutical products. The company is headquartered in Warrendale, PA.

Coeptis Pharmaceuticals, Inc. operates as a biopharmaceutical firm. It develops Consensi, a combination drug that is indicated for the treatment of osteoarthritis (OA) pain and hypertension. The company was founded by Dave Mehalick, Christine Sheehy, and Dan Yerace and is headquartered in Wexford, PA.